(Post-pandemic Era)-Global The Neuraminidase Inhibitor Market Segment Research Report 2024

Report ID: 875662 | Published Date: Dec 2025 | No. of Page: 80 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Neuraminidase Inhibitor Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Neuraminidase Inhibitor Market by Value
      2.2.1 Global The Neuraminidase Inhibitor Revenue by Type
      2.2.2 Global The Neuraminidase Inhibitor Market by Value (%)
    2.3 Global The Neuraminidase Inhibitor Market by Production
      2.3.1 Global The Neuraminidase Inhibitor Production by Type
      2.3.2 Global The Neuraminidase Inhibitor Market by Production (%)

3. The Major Driver of The Neuraminidase Inhibitor Industry
    3.1 Historical & Forecast Global The Neuraminidase Inhibitor Demand
    3.2 Largest Application for The Neuraminidase Inhibitor (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Neuraminidase Inhibitor Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Neuraminidase Inhibitor Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Neuraminidase Inhibitor Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Neuraminidase Inhibitor Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Neuraminidase Inhibitor Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Neuraminidase Inhibitor Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Neuraminidase Inhibitor Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Neuraminidase Inhibitor Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Neuraminidase Inhibitor Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Neuraminidase Inhibitor Average Price Trend
    12.1 Market Price for Each Type of The Neuraminidase Inhibitor in US (2017-2021)
    12.2 Market Price for Each Type of The Neuraminidase Inhibitor in Europe (2017-2021)
    12.3 Market Price for Each Type of The Neuraminidase Inhibitor in China (2017-2021)
    12.4 Market Price for Each Type of The Neuraminidase Inhibitor in Japan (2017-2021)
    12.5 Market Price for Each Type of The Neuraminidase Inhibitor in India (2017-2021)
    12.6 Market Price for Each Type of The Neuraminidase Inhibitor in Korea (2017-2021)
    12.7 Market Price for Each Type of The Neuraminidase Inhibitor in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Neuraminidase Inhibitor Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Neuraminidase Inhibitor

14. The Neuraminidase Inhibitor Competitive Landscape
     14.1 GlaxoSmithKline
        14.1.1 GlaxoSmithKline Company Profiles
        14.1.2 GlaxoSmithKline Product Introduction
        14.1.3 GlaxoSmithKline The Neuraminidase Inhibitor Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 BioCryst
        14.2.1 BioCryst Company Profiles
        14.2.2 BioCryst Product Introduction
        14.2.3 BioCryst The Neuraminidase Inhibitor Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Gilead Sciences
        14.3.1 Gilead Sciences Company Profiles
        14.3.2 Gilead Sciences Product Introduction
        14.3.3 Gilead Sciences The Neuraminidase Inhibitor Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 F. Hoffman-La Roche
        14.4.1 F. Hoffman-La Roche Company Profiles
        14.4.2 F. Hoffman-La Roche Product Introduction
        14.4.3 F. Hoffman-La Roche The Neuraminidase Inhibitor Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Daiichi Sankyo
        14.5.1 Daiichi Sankyo Company Profiles
        14.5.2 Daiichi Sankyo Product Introduction
        14.5.3 Daiichi Sankyo The Neuraminidase Inhibitor Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Neuraminidase Inhibitor Industry (Volume)
    Figure 2. The Neuraminidase Inhibitor Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Neuraminidase Inhibitor Revenue in 2021
    Figure 5. US The Neuraminidase Inhibitor Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Neuraminidase Inhibitor Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Neuraminidase Inhibitor Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Neuraminidase Inhibitor Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Neuraminidase Inhibitor Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Neuraminidase Inhibitor Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Neuraminidase Inhibitor Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Neuraminidase Inhibitor Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Neuraminidase Inhibitor Production, by Type (K Unit) (2017-2027)
    Table 5. The Neuraminidase Inhibitor Demand (K Unit) by Application (2017-2027)
    Table 6. The Neuraminidase Inhibitor Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Neuraminidase Inhibitor Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Neuraminidase Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Neuraminidase Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Neuraminidase Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Neuraminidase Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Neuraminidase Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Neuraminidase Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Neuraminidase Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Neuraminidase Inhibitor in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Neuraminidase Inhibitor in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Neuraminidase Inhibitor in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Neuraminidase Inhibitor in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Neuraminidase Inhibitor in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Neuraminidase Inhibitor in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Neuraminidase Inhibitor in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. GlaxoSmithKline Profiles
    Table 61. GlaxoSmithKline The Neuraminidase Inhibitor Product Introduction
    Table 62. GlaxoSmithKline The Neuraminidase Inhibitor Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. GlaxoSmithKline Strategic initiatives
    Table 64. BioCryst Profiles
    Table 65. BioCryst The Neuraminidase Inhibitor Product Introduction
    Table 66. BioCryst The Neuraminidase Inhibitor Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. BioCryst Strategic initiatives
    Table 68. Gilead Sciences Profiles
    Table 69. Gilead Sciences The Neuraminidase Inhibitor Product Introduction
    Table 70. Gilead Sciences The Neuraminidase Inhibitor Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Gilead Sciences Strategic initiatives
    Table 72. F. Hoffman-La Roche Profiles
    Table 73. F. Hoffman-La Roche The Neuraminidase Inhibitor Product Introduction
    Table 74. F. Hoffman-La Roche The Neuraminidase Inhibitor Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. F. Hoffman-La Roche Strategic initiatives
    Table 76. Daiichi Sankyo Profiles
    Table 77. Daiichi Sankyo The Neuraminidase Inhibitor Product Introduction
    Table 78. Daiichi Sankyo The Neuraminidase Inhibitor Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Neuraminidase Inhibitor Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Neuraminidase Inhibitor Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Neuraminidase Inhibitor Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports